D. Harper

发表

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™]

S. Keam, D. Harper, 2012, BioDrugs.

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted Adsorbed) [Cervarix™]

S. Keam, D. Harper, 2008, Drugs.

Image analysis for discrimination of cervical neoplasia.

B. Pogue, D. Harper, M. Mycek, 2000, Journal of biomedical optics.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Henry C Kitchener, Bart Spiessens, Frank Struyf, 2007, The Lancet.

HPV vaccines - A review of the first decade.

D. Harper, L. Demars, 2017, Gynecologic oncology.

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

M. Phipps, K. Bibbins-Domingo, D. Grossman, 2016, JAMA.

Clinical diagnosis of vaginitis was moderately accurate in symptomatic women

D. Harper, 2009, Evidence-based medicine.

Principles of nonstress testing in pregnancy.

D. Harper, T. Myrick, 1996, The Journal of family practice.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Daron G Ferris, Diane M Harper, Gary Dubin, 2004, The Lancet.

Analysis of acetic acid-induced whitening of high-grade squamous intraepithelial lesions.

B W Pogue, B. Pogue, D. Harper, 2001, Journal of biomedical optics.

3q26 Amplification Is an Effective Negative Triage Test for LSIL: A Historical Prospective Study

G. D. Harris, D. Harper, P. Tsipouras, 2012, PloS one.

Prevention of HPV-Associated Diseases in the United States

D. Harper, 2012 .

HPV vaccine against HPV infection and disease in males.

D. Harper, 2011, The New England journal of medicine.

Currently approved prophylactic HPV vaccines

D. Harper, 2009, Expert review of vaccines.

Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the Phase II and III trials

D. Harper, 2008 .

Factors Affecting the Detection Rate of Human Papillomavirus

D. Harper, M. Longacre, B. Cole, 2003, The Annals of Family Medicine.

Prevention strategies of cervical cancer in the HPV vaccine era.

D. Harper, X. Bosch, 2006, Gynecologic oncology.

Preliminary HPV vaccine results for women older than 25 years

D. Harper, 2009, The Lancet.

Urban and Rural Safety Net Health Care System Clinics: No Disparity in HPV4 Vaccine Completion Rates

G. D. Harris, D. Harper, A. Bonham, 2014, PloS one.

US women screen at lower rates for both cervical and colorectal cancers than a single cancer

Ananda Sen, D. Harper, M. Plegue, 2021, medRxiv.

Cancer risk perception and knowledge and physician communication behaviors: specific influences on cervical cancer and colorectal cancer screening in women 50-65 years old

D. Harper, K. Resnicow, M. Tariq, 2021, medRxiv.

Predictors of screening for cervical and colorectal cancer in women 50–65 years old in a multi-ethnic population

Ananda Sen, D. Harper, K. Resnicow, 2021, Preventive medicine reports.

The future of cancer screening after COVID‐19 may be at home

D. Harper, M. Jimbo, S. Gorin, 2020, Cancer.

Prevention of Human Papillomavirus Infections and Associated Diseases by Vaccination: A New Hope for Global Public Health

D. Harper, 2009, Public Health Genomics.

Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16/18 infection and cervical disease in women 15-25 years of age.

D. Harper, 2008, Gynecologic oncology.

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women

D. Harper, A. Moscicki, E. Franco, 2019, Sexually transmitted diseases.

Magnification and chromoscopy with the acetic acid test.

D. Harper, H. B. Kaufman, 2004, Endoscopy.

HPV vaccine against HPV infection and disease in males.

D. Harper, 2011, The New England journal of medicine.

Self-reported desire to improve colposcopic impressions

D. Harper, K. M. Parke, J. L. Cobb, 2000, Archives of Gynecology and Obstetrics.

Current prophylactic HPV vaccines and gynecologic premalignancies

D. Harper, 2009, Current opinion in obstetrics & gynecology.

Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population

R. Baumgartner, D. Harper, K. Baumgartner, 2015, Preventive medicine reports.

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

J. T. Cox, C. Wheeler, D. Harper, 2007, CA: a cancer journal for clinicians.

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

J. T. Cox, W. Lawrence, C. Wheeler, 2006, Journal of the National Cancer Institute.

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

C. Wheeler, D. Harper, A. Moscicki, 2006, The Lancet.

Age for HPV vaccination.

D. Harper, J. Paavonen, 2008, Vaccine.

Hypothesis generating data – HPV vaccines – A decade in review

D. Harper, L. Demars, 2017, Gynecologic oncology reports.

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.

H. Kitchener, M. Lehtinen, D. Harper, 2012, Gynecologic oncology.

Associations between prior HPV4 vaccine doses and cervical cancer screening participation.

R. Baumgartner, D. Harper, K. Baumgartner, 2016, Cancer epidemiology.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

D. Lowy, C. Wheeler, S. Wacholder, 2015, The Lancet. Oncology.

No evidence in US of HPV16/18 cancer precursor reduction.

D. Harper, M. Ruffin, M. E. Pendleton, 2016, Vaccine.

Will increasing dosing intervals decrease the loss of anti-HPV seropositivity over time?

D. Harper, L. Demars, R. Meza, 2018, Vaccine.

Correction: Intent to Participate in Future Cervical Cancer Screenings Is Lower when Satisfaction with the Decision to Be Vaccinated Is Neutral

D. Harper, N. Alexander, J. Comes, 2014, PLoS ONE.

Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed--biologic concordance and women's preferences.

D. Harper, B. Cole, D. Belloni, 2002, American journal of obstetrics and gynecology.

Women Have a Preference for Their Male Partner to Be HPV Vaccinated

D. Harper, N. Alexander, J. Comes, 2014, PloS one.

Cervical cancer incidence can increase despite HPV vaccination.

M. Lehtinen, D. Harper, J. Paavonen, 2010, The Lancet. Infectious diseases.

Healing experiences after cervical cryosurgery.

D. Harper, T. Daaleman, C. Johnson, 2000, The Journal of family practice.

The natural history of cervical cryosurgical healing. The minimal effect of debridement of the cervical eschar.

D. Harper, D. Ferris, T. Daaleman, 2000, Journal of lower genital tract disease.

Cervical mucosal block effectively reduces the pain and cramping from cryosurgery.

D. Harper, J. L. Cobb, 1998, The Journal of family practice.

Paracervical block diminishes cramping associated with cryosurgery.

D. Harper, 1997, The Journal of family practice.

Pain and cramping associated with cryosurgery.

D. Harper, 1994, The Journal of family practice.

Current findings from prophylactic HPV vaccine trials

D. Harper, L. Koutsky, 2006 .

Who should be targeted for vaccination against anal cancer?

D. Harper, Stephen L Vierthaler, 2011, The Lancet. Oncology.

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

M. Lehtinen, D. Harper, S. Garland, 2013, The Journal of infectious diseases.

Why Am I Scared of HPV?

D. Harper, 2004, CA: a cancer journal for clinicians.

Postpartum endometritis and infection following incomplete or complete abortion: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data

J. Stringer, S. Kochhar, D. Harper, 2019, Vaccine.

Gardasil® needs a new consent form

D. Harper, 2009, Expert review of vaccines.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Daron G Ferris, Cosette M Wheeler, Diane M Harper, 2007, The New England journal of medicine.

Review: oral and intravaginal agents are equally effective for treatment of uncomplicated vulvovaginal candidiasis

D. Harper, 2002, ACP Journal Club.

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

C. Wheeler, D. Harper, S. Garland, 2007, The Lancet.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Cosette M Wheeler, Diane M Harper, Mark H Stoler, 2005, The Lancet. Oncology.

Review of Gardasil.

D. Harper, J. Santee, Stephen L Vierthaler, 2010, Journal of vaccines & vaccination.

Speculation overinflates long-term efficacy of vaccine for anal dysplasia.

D. Harper, G. Talboy, Kamani Lankachandra, 2013, The Lancet. Oncology.

Effi cacy of a prophylactic adjuvanted bivalent L 1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women : an interim analysis of a phase III double-blind , randomised controlled trial

C. Wheeler, H. Kitchener, M. Lehtinen, 2007 .

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, The Lancet. Oncology.

Long-Term Follow-Up of HPV16-Positive Women: Persistence of the Same Genetic Variant and Low Prevalence of Variant Co-Infections

D. Harper, W. Quint, D. Geraets, 2013, PloS one.

Smoking Enhances Risk for New External Genital Warts in Men

D. Harper, D. Elashoff, R. Cook, 2009, International journal of environmental research and public health.

Cervico-Isthmic Corporeal Pregnancy With Delivery at Term: A Review of the Literature With a Case Report

Michael A. Wells, D. Harper, D. Avery, 2009, Obstetrical & gynecological survey.

Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study.

Diane M Harper, D. Harper, Francisco A. R. Garcia, 2004, American journal of obstetrics and gynecology.

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.

C. Wheeler, R. Railkar, M. Lehtinen, 2006, Vaccine.

Primary strategies for HPV infection and cervical cancer prevention.

D. Harper, L. Demars, 2014, Clinical obstetrics and gynecology.

Leukocytes in the Cervix: A Quantitative Evaluation of Cervicitis

D. Harper, A. Givan, J. Stern, 1998, Obstetrics and gynecology.

Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.

D. Harper, M. Jimbo, 2021, The Lancet. Infectious diseases.

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

C. Wheeler, M. Lehtinen, D. Harper, 2017, Journal of the National Cancer Institute.

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

D. Harper, A. Moscicki, P. Naud, 2016, BMJ Open.

Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases

D. Harper, D. Apter, J. Paavonen, 2016, Expert review of vaccines.

Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA

Frank Struyf, Brigitte Colau, Cosette M Wheeler, 2014, Clinical and Vaccine Immunology.

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females

D. Harper, Stephen L Vierthaler, 2011, ISRN obstetrics and gynecology.

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

C. Wheeler, D. Harper, A. Moscicki, 2009, The Lancet.

Human papillomavirus and HPV vaccines: a review.

S. Franceschi, W. Edmunds, D. Harper, 2007, Bulletin of the World Health Organization.

Prevent Cervical Cancer and Its Precursors American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to

J. T. Cox, C. Wheeler, D. Harper, 2007 .

Chapter 13: Current findings from prophylactic HPV vaccine trials.

D. Harper, L. Koutsky, 2006, Vaccine.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized, controlled trial

C. Wheeler, D. Harper, W. Quint, 2005 .

Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement.

M. Phipps, K. Bibbins-Domingo, D. Grossman, 2016, JAMA.

Spontaneous rupture of unscarred uterus in a primigravida with preterm prelabour rupture of membranes

D. Harper, P. B. Greenspan, Wael Sayed Mourad, 2015, BMJ Case Reports.

Recognizing and Treating Premenstrual Dysphoric Disorder

D. Harper, B. Liang, P. Batra, 2002 .

Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, International journal of cancer.

Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.

D. Harper, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts

D. Harper, M. Heilemann, D. Elashoff, 2005, International journal of STD & AIDS.

Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.

D. Harper, E. Franco, 2005, Vaccine.

Collection devices for human papillomavirus.

J. Vaught, D. Harper, A. Hildesheim, 1999, The Journal of family practice.

Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials

S. Wacholder, M. Sherman, M. Schiffman, 2018, The Journal of infectious diseases.

Cervical intraepithelial neoplasia in pregnancy.

D. Harper, M. Roach, 1996, The Journal of family practice.

Efficacy of a bivalent L 1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial

Daron G Ferris, Wim Quint, Diane M Harper, 2005 .

Prenatal predictors of cesarean section due to labor arrest

D. Harper, W. Harper, C. A. Johnson, 2004, Archives of Gynecology and Obstetrics.

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up.

E. Calleja, D. Harper, M. Einstein, 2019, Gynecologic oncology.

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study

C. Wheeler, D. Harper, C. Vallejos, 2016, International journal of cancer.

Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally

D. Harper, Hunter K. Holt, C. Peterson, 2023, Frontiers in Public Health.

Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies.

D. Harper, K. Williams, 2010, Discovery medicine.

The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study

D. Harper, C. Bassis, M. Ruffin, 2020, Gynecology and pelvic medicine.

Tampon Samplings With Longer Cervicovaginal Cell Exposures Are Equivalent to Two Consecutive Swabs for the Detection of High-Risk Human Papillomavirus

D. Harper, B. Cole, Meghan Raymond, 2002, Sexually transmitted diseases.

Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement.

M. Phipps, K. Bibbins-Domingo, D. Grossman, 2016, JAMA.

Review: Vitamin B6 is beneficial in the premenstrual syndrome

D. Harper, 1999, ACP Journal Club.

In a Safety Net Population HPV4 Vaccine Adherence Worsens as BMI Increases

G. D. Harris, D. Harper, A. Bonham, 2014, PloS one.

Influencers and preference predictors of HPV vaccine uptake among US male and female young adult college students

D. Harper, A. Lajoie, R. Clover, 2018, Papillomavirus research.

Interdisciplinary, Inclusive, and Innovative: Promoting a Paradigmatic Shift in Cancer Research Among Transgender and Gender Diverse Adolescents and Young Adults

D. Harper, L. Bauerband, S. Kattari, 2022, Annals of LGBTQ Public and Population Health.

Three large scale surveys highlight the complexity of cervical cancer under-screening among women 45–65 years of age in the United States

D. Harper, M. Plegue, M. Jimbo, 2019, Preventive medicine.

HPV testing: Psychosocial and cost-effectiveness studies of screening and HPV disease

D. Harper, Z. Philips, D. Jenkins, 2001 .

Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.

D. Harper, M. Halpern, S. Sorensen, 2000, Archives of family medicine.

JM-JABF210069 509..521

Ananda Sen, D. Harper, Elizabeth K Haro, 2021 .

Substantial impact on precancerous lesions and HPV infections through 5.5 years in women vaccinated with the HPV-16/18 L1 VLP AS04 candidate vaccine

C. Wheeler, D. Harper, W. Quint, 2007 .

HPV vaccination bridges to HPV screening

D. Harper, S. S. Sheinfeld Gorin, 2020, EClinicalMedicine.

Prophylactic HPV Vaccines and Prevention of Cervical Intraepithelial Neoplasia

D. Harper, E. Heitmann, 2012, Current Obstetrics and Gynecology Reports.

Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention

D. Harper, N. Alexander, J. Comes, 2014, PloS one.

Reduction in HPV prevalence--no evidence to support HPV vaccination reduces HPV prevalence.

G. D. Harris, D. Harper, Jennifer A Groner, 2014, The Journal of infectious diseases.

Quantifying Clinical HPV4 Dose Inefficiencies in a Safety Net Population

D. Harper, Jeffrey Wall, Inge Verdenius, 2013, PloS one.

Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest

G. D. Harris, D. Harper, R. Bekkers, 2013, PloS one.

Time-Resolved Imaging of Cervical Acetowhitening

Philippe Schmid-Saugeon, Alex R. Zelenchuk, Jonathan D. Pitts, 2004 .

Cancer risk perception and physician communication behaviors on cervical cancer and colorectal cancer screening

D. Harper, K. Resnicow, Minal R. Patel, 2021, eLife.

Predictors of Human Papillomavirus Seropositivity in Appalachian Women Aged 18 to 26 Years

D. Harper, E. Hade, E. Paskett, 2021, Sexually transmitted diseases.

Intent to Participate in Future Cervical Cancer Screenings Is Lower when Satisfaction with the Decision to Be Vaccinated Is Neutral

D. Harper, N. Alexander, J. Comes, 2014, PloS one.

IIV3 reduced flu in HIV pregnant women and infants, and in HIV+ pregnant women but not their infants

D. Harper, Luz M. Fernandez, R. Wright, 2015, Annals of Internal Medicine.

The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series.

G. D. Harris, D. Harper, Jeffrey Wall, 2014, Preventive medicine.

Positive High-Risk HPV Test with Negative Cytology—A Conundrum and Blessing of Our Latest Technology

D. Harper, Jennifer A Groner, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines

C. Wheeler, R. Railkar, D. Harper, 2007, Clinical and Vaccine Immunology.

Review: several non-pharmacological, pharmacological, and surgical treatments may be effective in urinary incontinence

D. Harper, 2004 .

Incorporating Osteopathic Curriculum Into a Family Medicine Residency.

D. Harper, Laura K. Hempstead, 2015, Family Medicine.

The Efficacy of Topical Benzocaine Gel in Providing Anesthesia Prior to Cervical Biopsy and Endocervical Curettage

D. Harper, D. Ferris, M. Litaker, 1997, Journal of Lower Genital Tract Disease.

Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement.

M. Phipps, K. Bibbins-Domingo, D. Grossman, 2016, JAMA.

Beyond the Pap: assessing patients' priorities for the annual examination.

D. Harper, Meghan R Longacre, Heidi I Becker, 2004, Journal of women's health.

Conclusions about the quadrivalent human papillomavirus vaccine efficacy based on alternate dosing schedules and less than three dose immunogenicity is inappropriate.

D. Harper, 2014, The Journal of infectious diseases.

Cross protection against HPV might prevent type replacement.

D. Harper, Inge Verdenius, Jennifer A Groner, 2013, The Lancet. Infectious diseases.

Cervico-Isthmic Corporeal Pregnancy With Delivery at Term: A Review of the Literature With a Case Report

Michael A. Wells, D. Harper, D. Avery, 2009, Obstetrical & gynecological survey.

Current prophylactic HPV vaccines and gynecologic premalignancies

D. Harper, 2009, Current opinion in obstetrics & gynecology.

and persistent infection with non-vaccine oncogenic HPV types using an alternative

D. Harper, S. Garland, P. Naud, 2014 .

Does comprehensive preventive medicine training enhance clinical prevention?

D. Harper, N. Comninellis, 1997, Family medicine.